Imperial College London

Dr Hannah M Cheeseman

Faculty of MedicineDepartment of Infectious Disease

Postdoctoral Researcher & Clinical Trials Laboratory Manager



+44 (0)20 7594 2540hannah.cheeseman




457 - Shattock GroupNorfolk PlaceSt Mary's Campus






Pollock KM, Cheeseman HM, Szubert AJ, et al., 2022, Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial, Eclinicalmedicine, Vol:44, ISSN:2589-5370

Cole ME, Guo Y, Cheeseman HM, et al., 2022, Multicolor Flow Cytometry and High-Dimensional Data Analysis to Probe Complex Questions in Vaccinology., Methods Mol Biol, Vol:2414, Pages:433-447

Moshe M, Daunt A, Flower B, et al., 2021, SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (REACT2): diagnostic accuracy study, Bmj: British Medical Journal, Vol:372, ISSN:0959-535X, Pages:1-8

Klein K, Nankya I, Nickel G, et al., 2021, Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1, Journal of Virology, Vol:95, ISSN:0022-538X

Tregoning JS, Brown ES, Cheeseman HM, et al., 2020, Vaccines for COVID-19, Clinical and Experimental Immunology, Vol:202, ISSN:0009-9104, Pages:162-192

More Publications